Assorted content to end your week.
- Philip Ritchie writes about new research into natural receptors which may help limit infection by COVID-19 and other viruses, while Alice Klein reports on the development of an inhaled powder which could line the respiratory tract to provide an additional layer of protection. But Spencer Kimball's report on Pfizer's windfall profits (racked up as it inflates the cost of vaccines and treatments) serves as a warning as to why the means of protecting public health can't be put into corporate hands.
- Meanwhile, David Moscrop weighs in on Loblaws' profiteering as it falsely blames others for inflated prices while bringing in obscene profits.
- Robert Reich points out that the current corporate stranglehold on public policy is the result of the working class losing sight of the importance of class politics during the Keynesian consensus. And Canadians for Tax Fairness examines how corporations exploited that dynamic to turn massive COVID subsidies into cash cows while public anger was selectively directed at individuals receiving money to survive.
- Linda McQuaig discusses how private foundations serve to further the power and shelter the assets of the wealthy few while actual charities struggle to stay afloat. And Angella MacEwen offers a warning that the "employee ownership trust" system mentioned in yesterday's post is designed primarily to funnel money to departing capitalists rather than to give workers any meaningful benefit.
- Finally, Umair Irfan reports on new research showing that even a relatively modest transition to electric vehicles can lead to substantial improvements in respiratory health.
No comments:
Post a Comment